Efficacy and safety of eltrombopag in Chinese patients with refractory or relapsed severe aplastic anemia

For patients with severe aplastic anemia (SAA) in China who have had an insufficient response to the first-line treatment with hematopoietic stem cell transplantation or immunosuppressive therapy, there is no established standard of care other than transfusion support and treatment of infections. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Hong, He, Guangsheng, Fu, Rong, Li, Fei, Han, Bing, Li, Tao, Liu, Lei, Mittal, Hemant, Jin, Hantao, Zhang, Fengkui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622422/
https://www.ncbi.nlm.nih.gov/pubmed/37919313
http://dx.doi.org/10.1038/s41598-023-45607-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622422/
https://www.ncbi.nlm.nih.gov/pubmed/37919313
http://dx.doi.org/10.1038/s41598-023-45607-0

Ejemplares similares